查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829845

2025年全球荷爾蒙子宮內避孕器（IUD）市場報告

Hormonal Intrauterine Devices (IUDs) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，荷爾蒙子宮內避孕器 (IUD) 市場快速擴張，從 2024 年的 26.1 億美元成長至 2025 年的 28.7 億美元，複合年成長率達 10.2%。這一歷史性成長可歸因於更安全、更有效的荷爾蒙製劑的開發、對長期避孕解決方案的需求不斷成長、醫療保健提供者的推薦增加、公眾對避孕選擇的認知不斷提高，以及醫療技術和器械設計的進步。

預計未來幾年荷爾蒙子宮內避孕器 (IUD) 市場將快速成長，到 2029 年將達到 42.9 億美元，複合年成長率為 10.6%。預測期內成長的主要促進因素包括：人們對避孕選擇的認知不斷提高、對長效可逆避孕的偏好日益成長、設備安全性和有效性的進步、對個人化醫療保健的日益重視以及醫療保健提供者的廣泛普及。預測期內的主要趨勢包括：設備技術的進步、避孕選擇的個人化程度不斷提高、以患者為中心的醫療保健方法的興起、對永續和環保產品的需求不斷成長以及新型避孕產品的開發。

子宮內避孕器（IUD）是一種小型的T形塑膠裝置，可置入子宮並釋放合成的黃體素。這些裝置透過增稠子宮頸黏液來阻斷精子，使子宮內膜變薄以防止著床，有時還能抑制排卵，從而達到避孕的目的。它們還可以減少月經出血和經痛，在某些情況下甚至可以完全停止月經。

荷爾蒙子宮內避孕器的主要類型包括13毫克、19毫克和52毫克。 13毫克的激素子宮內避孕器可釋放低劑量激素，最長可達三年，在尋求長效避孕且激素暴露較少的女性中越來越受歡迎。這類節育器設計多樣，包括有框和無框子宮內避孕器，並包含不同的荷爾蒙類型，例如釋放levonorgestrel和釋放孕酮的子宮內避孕器。這些選擇適合不同年齡段，包括20-24歲、25-34歲和35-44歲。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供了您在激素宮內節育器 (IUD) 行業取得成功所需的所有數據，涵蓋激素宮內節育器 (IUD) 市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的激素宮內節育器 (IUD) 細分市場、市場佔有率和詳細的激素宮內節育器 (IUD) 市場、市場佔有率和詳細的激素宮內節育器 (IUD) 市場、市場佔有率和詳細的激素宮內節育器 (IUD) 市場。本激素子宮內避孕器 (IUD) 市場研究報告透過對產業現狀和未來情況的詳細分析，為您提供完整的展望。

未來五年預測成長率為10.6%，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自芬蘭和瑞士等主要地區的levonorgestrel緩釋儲藥器和T型聚合物框架徵收關稅直接影響美國，並可能導致避孕選擇減少和長期避孕成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響可能會更加廣泛。

意外懷孕發生率的上升預計將推動荷爾蒙避孕器器市場的未來成長。意外妊娠是指在受孕時未計劃或不想要的妊娠，原因可能多種多樣，包括避孕失敗、缺乏避孕途徑、避孕不當以及性暴力。有效避孕途徑的匱乏降低了個人對生育選擇的自主權，並增加了意外懷孕的可能性。荷爾蒙子宮內避孕器在避孕方面非常有效，失敗率低於1%。它們能夠提供長期保護（根據類型，保護期為3-7年），是希望避免意外妊娠人士的可靠選擇。例如，2023年8月，英國衛生和社會保障部下屬政府機構健康改善與不平等辦公室報告稱，2022年1月至6月期間，英格蘭和威爾斯居民共進行了123,219次墮胎，與2021年同期相比增加了17%。因此，意外懷孕的增加正在促進荷爾蒙子宮內避孕器市場的成長。

荷爾蒙子宮內避孕器市場的主要參與者正致力於開發先進產品，例如levonorgestrel子宮內釋放系統，為女性提供更個人化的避孕解決方案。levonorgestrel子宮內釋放系統 (LNG-IUS) 是一種荷爾蒙子宮內避孕器，可在子宮內穩定釋放合成levonorgestrel。這種荷爾蒙會使子宮頸黏液變稠，改變子宮內膜，並阻止精子到達卵子。例如，2022 年 11 月，致力於改善女性獲得基本藥物和保健產品的美國製藥組織 Medicines360 推出了 FDA核准的LILETTA。 Liletta 是美國現有持續時間最長的荷爾蒙子宮內避孕器之一，核准用於避孕長達八年，用於治療月經過多長達五年。這種子宮內避孕器在廣泛人群中避孕的有效率約為 99%。它配備符合人體工學的插入器，方便醫生在諮詢時輕鬆插入，並可隨時取出。 Liletta 以處方箋購買，並透過 340B 藥品定價計劃以折扣價出售，這與 Medicines360 提升女性醫療保健可及性的使命相一致。

2024年1月，Medicines360與DKT WomanCare Global合作。 DKT WomanCare Global是一家總部位於法國的公司，專注於女性性與生殖健康產品的可近性、可近性和可及性。此次策略合作旨在提高人們對Avibela（一款價格實惠的荷爾蒙子宮內避孕器）的認知度，並擴大市場覆蓋範圍，尤其是在醫療資源匱乏的地區，從而提高產品的可及性和可及性，改善全球性與生殖健康。

荷爾蒙子宮內避孕器 (IUD) 市場包括荷爾蒙儲存器、線繩以及置入和取出裝置的銷售。此市場的價值是指“出廠價”，即產品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的產品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球荷爾蒙子宮內避孕器 (IUD)：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球荷爾蒙子宮內避孕器（IUD）市場：成長率分析
  • 全球荷爾蒙子宮內避孕器 (IUD) 市場表現：規模與成長，2019-2024 年
  • 全球子宮內避孕器 (IUD) 市場預測：2024-2029 年及 2034 年規模與成長
  • 全球荷爾蒙子宮內避孕器（IUD）：總目標市場（TAM）

第6章 市場細分

  • 全球荷爾蒙子宮內避孕器 (IUD) 市場類型、表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 13毫克激素子宮內避孕器
  • 19毫克激素子宮內避孕器
  • 52毫克激素子宮內避孕器
  • 全球荷爾蒙子宮內避孕器 (IUD) 市場（按裝置設計、實際情況和預測），2019-2024 年、2024-2029 年、2034 年
  • 框架式子宮內避孕器
  • 無框架子宮內避孕器
  • 全球子宮內避孕器 (IUD) 市場（依荷爾蒙類型、實際規模及預測），2019-2024 年、2024-2029 年、2034 年
  • levonorgestrel子宮內避孕器
  • 釋放孕酮的子宮內避孕器
  • 全球荷爾蒙子宮內避孕器 (IUD) 市場：按應用、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 20-24歲
  • 25-34歲
  • 35至44歲
  • 其他用途
  • 全球荷爾蒙子宮內避孕器 (IUD) 市場：按 13 毫克激素子宮內避孕器 (IUD) 類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 低劑量13毫克子宮內避孕器
  • 針對特定情況的專用 13mg 子宮內避孕器
  • 全球荷爾蒙子宮內避孕器 (IUD) 市場：19 毫克激素子宮內避孕器細分市場（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 低劑量19毫克子宮內避孕器
  • 針對特定情況的專用 19mg 子宮內避孕器
  • 全球荷爾蒙子宮內避孕器 (IUD) 市場：按 52 毫克激素子宮內避孕器 (IUD) 類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 標準 52mg 子宮內避孕器
  • 緩釋性52mg 子宮內避孕器
  • 52毫克子宮內避孕器推薦用於治療月經過多和子宮內膜異位症

第7章 區域和國家分析

  • 全球子宮內避孕器 (IUD) 市場：區域分析、預測與趨勢（2019-2024 年、2024-2029 年及 2034 年）
  • 全球子宮內避孕器 (IUD) 市場：國家/地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 子宮內避孕器（IUD）市場：競爭格局
  • 子宮內避孕器（IUD）市場：公司簡介
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Organon & Companies Overview, Products and Services, Strategy and Financial Analysis
    • Gedeon Richter Plc Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Meril Life Science Pvt Ltd.
  • Bharat Serums and Vaccines Limited
  • Teva UK Limited
  • EurimPharm
  • HRA Pharma SAS
  • Medicines360
  • Hll Lifecare Limited
  • Pregna International Ltd.
  • Allergan plc
  • Actavis Inc.
  • DKT WomanCare Global
  • CrossBay Medical Inc.
  • SMB Corporation of India
  • Oy Leiras
  • OCON Healthcare

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年子宮內避孕器（IUD）市場：哪些國家將提供新機會
  • 2029年子宮內避孕器（IUD）市場：細分市場帶來新機會
  • 2029年子宮內避孕器（IUD）市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31957u

Hormonal intrauterine devices (IUDs) are small, T-shaped plastic devices that are inserted into the uterus and release progestin, a synthetic hormone. These devices prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to impede implantation, and sometimes suppressing ovulation. Additionally, they can reduce menstrual bleeding and cramping, and in some cases, may stop periods altogether.

The primary types of hormonal IUDs include 13-milligram, 19-milligram, and 52-milligram hormonal IUDs. The 13-milligram hormonal IUDs, which release a low dose of hormones for up to three years, are becoming increasingly popular among women seeking long-acting contraceptive options with lower hormone exposure. The design of these devices varies, including framed and frameless IUDs, and they feature different hormone types such as levonorgestrel-releasing and progesterone-releasing IUDs. These options cater to various age groups, including those aged 20-24, 25-34, and 35-44, among other applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hormonal intrauterine devices (IUDs) market research report is one of a series of new reports from The Business Research Company that provides hormonal intrauterine devices (IUDs) market statistics, including hormonal intrauterine devices (IUDs) industry global market size, regional shares, competitors with a hormonal intrauterine devices (IUDs) market share, detailed hormonal intrauterine devices (IUDs) market segments, market trends, and opportunities, and any further data you may need to thrive in the hormonal intrauterine devices (IUDs) industry. This hormonal intrauterine device (IUDs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormonal intrauterine devices (iuds) market size has grown rapidly in recent years. It will grow from $2.61 billion in 2024 to $2.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to the development of safer and more effective hormonal formulations, rising demand for long-term birth control solutions, increasing healthcare provider recommendations, greater public awareness of contraceptive options, and advancements in medical technology and device design.

The hormonal intrauterine devices (iuds) market size is expected to see rapid growth in the next few years. It will grow to $4.29 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising awareness of contraceptive choices, increasing preference for long-acting reversible contraception, advancements in device safety and efficacy, growing emphasis on personalized healthcare, and broader availability through healthcare providers. Major trends in the forecast period include advancements in device technology, increasing personalization of contraceptive options, growth in patient-centric healthcare approaches, rising demand for sustainable and eco-friendly products, development of new contraceptive products.

The forecast of 10.6% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on levonorgestrel-eluting reservoirs and T-shaped polymer frames, sourced from key regions such as Finland and Switzerland, which could lead to reduced contraceptive options and higher costs for long-term birth control methods.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of unwanted pregnancies is projected to drive the growth of the hormonal intrauterine devices market in the future. Unwanted pregnancies refer to those that are not planned or desired at the time of conception and can arise from various factors, such as contraceptive failure, lack of access to birth control, improper use of contraception, or sexual violence. Limited access to effective contraceptive methods diminishes individuals' control over their reproductive choices, increasing the likelihood of unwanted pregnancies. Hormonal IUDs are highly effective in preventing pregnancy, boasting a failure rate of less than 1%. They offer long-term protection (ranging from 3 to 7 years, depending on the specific type) and serve as a reliable option for those looking to avoid unintended pregnancies. For example, in August 2023, the Office for Health Improvement & Disparities, a UK governmental unit within the Department of Health and Social Care, reported that between January and June 2022, there were 123,219 abortions among residents of England and Wales, representing a 17% increase compared to the same period in 2021. Thus, the rise in unwanted pregnancies is contributing to the growth of the hormonal intrauterine devices market.

Key players in the hormonal intrauterine devices market are focusing on developing advanced products, such as levonorgestrel-releasing intrauterine systems, to offer more personalized contraceptive solutions for women. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal IUDs that steadily release levonorgestrel, a synthetic progestin, into the uterus. This hormone thickens cervical mucus and modifies the uterine lining, preventing sperm from reaching the egg. For instance, in November 2022, Medicines360, a US-based pharmaceutical organization dedicated to improving women's access to essential medicines and health products, launched the FDA-approved LILETTA. LILETTA is one of the longest-lasting hormonal IUDs available in the U.S., approved for contraception for up to 8 years and for treating heavy menstrual bleeding for up to 5 years. It is approximately 99% effective in preventing pregnancy among diverse populations. The device comes with an ergonomic inserter for easy placement during a consultation and can be removed at any time by a healthcare provider. It is available by prescription, and LILETTA is offered at a reduced price through the 340B drug pricing program, aligning with Medicines360's mission to enhance access to women's healthcare.

In January 2024, Medicines360 formed a partnership with DKT WomanCare Global, a France-based company focused on the availability, accessibility, and affordability of sexual and reproductive health products for women. This strategic collaboration aims to enhance the availability and accessibility of the affordable hormonal IUD, Avibela, by raising awareness and expanding market reach, particularly in underserved areas, and is intended to improve global sexual and reproductive health.

Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hormonal intrauterine devices (IUDs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormonal intrauterine devices (IUDs) market consists of sales of hormone reservoir, strings, and insertion or removal instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormonal Intrauterine Devices (IUDs) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormonal intrauterine devices (iuds) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormonal intrauterine devices (iuds) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hormonal intrauterine devices (iuds) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: 13 Milligram Hormonal Intrauterine Devices; 19 Milligram Hormonal Intrauterine Devices; 52 Milligram Hormonal Intrauterine Devices
  • 2) By Device Design: Framed Intrauterine Devices; Frameless Intrauterine Devices
  • 3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices; Progesterone Releasing Intrauterine Devices
  • 4) By Application: Age 20-24; Age 25-34; Age 35-44; Other Applications
  • Subsegments:
  • 1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs; Specialty 13 Mg IUDs For Specific Conditions
  • 2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs; Specialty 19 Mg IUDs For Specific Conditions
  • 3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs; Extended-Release 52 Mg IUDs; Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
  • Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Organon & Companies; Gedeon Richter Plc; Meril Life Science Pvt Ltd.; Bharat Serums and Vaccines Limited; Teva UK Limited; EurimPharm; HRA Pharma SAS; Medicines360; Hll Lifecare Limited; Pregna International Ltd.; Allergan plc; Actavis Inc.; DKT WomanCare Global; CrossBay Medical Inc.; SMB Corporation of India; Oy Leiras; OCON Healthcare
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hormonal Intrauterine Devices (IUDs) Market Characteristics

3. Hormonal Intrauterine Devices (IUDs) Market Trends And Strategies

4. Hormonal Intrauterine Devices (IUDs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hormonal Intrauterine Devices (IUDs) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hormonal Intrauterine Devices (IUDs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hormonal Intrauterine Devices (IUDs) Market Growth Rate Analysis
  • 5.4. Global Hormonal Intrauterine Devices (IUDs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hormonal Intrauterine Devices (IUDs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hormonal Intrauterine Devices (IUDs) Total Addressable Market (TAM)

6. Hormonal Intrauterine Devices (IUDs) Market Segmentation

  • 6.1. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13 Milligram Hormonal Intrauterine Devices
  • 19 Milligram Hormonal Intrauterine Devices
  • 52 Milligram Hormonal Intrauterine Devices
  • 6.2. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Framed Intrauterine Devices
  • Frameless Intrauterine Devices
  • 6.3. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Levonorgestrel Releasing Intrauterine Devices
  • Progesterone Releasing Intrauterine Devices
  • 6.4. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Age 20-24
  • Age 25-34
  • Age 35-44
  • Other Applications
  • 6.5. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 13 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Low-Dose 13 Mg IUDs
  • Specialty 13 Mg IUDs For Specific Conditions
  • 6.6. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 19 Milligram Hormonal Intrauterine Devices,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Low-Dose 19 Mg IUDs
  • Specialty 19 Mg IUDs For Specific Conditions
  • 6.7. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 52 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard 52 Mg IUDs
  • Extended-Release 52 Mg IUDs
  • Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

7. Hormonal Intrauterine Devices (IUDs) Market Regional And Country Analysis

  • 7.1. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market

  • 8.1. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormonal Intrauterine Devices (IUDs) Market

  • 9.1. China Hormonal Intrauterine Devices (IUDs) Market Overview
  • 9.2. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormonal Intrauterine Devices (IUDs) Market

  • 10.1. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormonal Intrauterine Devices (IUDs) Market

  • 11.1. Japan Hormonal Intrauterine Devices (IUDs) Market Overview
  • 11.2. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormonal Intrauterine Devices (IUDs) Market

  • 12.1. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormonal Intrauterine Devices (IUDs) Market

  • 13.1. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormonal Intrauterine Devices (IUDs) Market

  • 14.1. South Korea Hormonal Intrauterine Devices (IUDs) Market Overview
  • 14.2. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormonal Intrauterine Devices (IUDs) Market

  • 15.1. Western Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • 15.2. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormonal Intrauterine Devices (IUDs) Market

  • 16.1. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormonal Intrauterine Devices (IUDs) Market

  • 17.1. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormonal Intrauterine Devices (IUDs) Market

  • 18.1. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormonal Intrauterine Devices (IUDs) Market

  • 19.1. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormonal Intrauterine Devices (IUDs) Market

  • 20.1. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market

  • 21.1. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • 21.2. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormonal Intrauterine Devices (IUDs) Market

  • 22.1. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormonal Intrauterine Devices (IUDs) Market

  • 23.1. North America Hormonal Intrauterine Devices (IUDs) Market Overview
  • 23.2. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormonal Intrauterine Devices (IUDs) Market

  • 24.1. USA Hormonal Intrauterine Devices (IUDs) Market Overview
  • 24.2. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormonal Intrauterine Devices (IUDs) Market

  • 25.1. Canada Hormonal Intrauterine Devices (IUDs) Market Overview
  • 25.2. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormonal Intrauterine Devices (IUDs) Market

  • 26.1. South America Hormonal Intrauterine Devices (IUDs) Market Overview
  • 26.2. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormonal Intrauterine Devices (IUDs) Market

  • 27.1. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormonal Intrauterine Devices (IUDs) Market

  • 28.1. Middle East Hormonal Intrauterine Devices (IUDs) Market Overview
  • 28.2. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormonal Intrauterine Devices (IUDs) Market

  • 29.1. Africa Hormonal Intrauterine Devices (IUDs) Market Overview
  • 29.2. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape And Company Profiles

  • 30.1. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape
  • 30.2. Hormonal Intrauterine Devices (IUDs) Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Organon & Companies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Gedeon Richter Plc Overview, Products and Services, Strategy and Financial Analysis

31. Hormonal Intrauterine Devices (IUDs) Market Other Major And Innovative Companies

  • 31.1. Meril Life Science Pvt Ltd.
  • 31.2. Bharat Serums and Vaccines Limited
  • 31.3. Teva UK Limited
  • 31.4. EurimPharm
  • 31.5. HRA Pharma SAS
  • 31.6. Medicines360
  • 31.7. Hll Lifecare Limited
  • 31.8. Pregna International Ltd.
  • 31.9. Allergan plc
  • 31.10. Actavis Inc.
  • 31.11. DKT WomanCare Global
  • 31.12. CrossBay Medical Inc.
  • 31.13. SMB Corporation of India
  • 31.14. Oy Leiras
  • 31.15. OCON Healthcare

32. Global Hormonal Intrauterine Devices (IUDs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormonal Intrauterine Devices (IUDs) Market

34. Recent Developments In The Hormonal Intrauterine Devices (IUDs) Market

35. Hormonal Intrauterine Devices (IUDs) Market High Potential Countries, Segments and Strategies

  • 35.1 Hormonal Intrauterine Devices (IUDs) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hormonal Intrauterine Devices (IUDs) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hormonal Intrauterine Devices (IUDs) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer